Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 74346M406 since 12/18/2024, newest first.
| Filer | % of Class | Filed | |
|---|---|---|---|
|
Michael S. Gordon
13G/A
Amendment 5
|
2.0% |
5/7/2026
Event 3/31/2026
|
|
| Michael S. Gordon | 2.0% | ||
| Title 19 Promis | 2.0% | ||
|
Armistice Capital, LLC
13G/A
Amendment 4
|
0.9% |
2/17/2026
Event 12/31/2025
|
|
| Armistice Capital, LLC | 0.9% | ||
| Steven Boyd | 0.9% | ||
|
Sphera Funds Management Ltd.
13G/A
Amendment 3
|
7.8% |
2/5/2026
Event 12/31/2025
|
|
| Sphera Funds Management Ltd. | 7.8% | ||
| Sphera Global Healthcare GP Ltd. | 7.8% | ||
| Sphera Global Healthcare Management LP. | 7.8% | ||
|
ABG Management Ltd.
13D/A
Amendment 1
|
11.3% |
2/2/2026
Event 1/29/2026
|
|
| ABG Management Ltd. | 11.3% | ||
| Ally Bridge Group (NY) LLC | 11.3% | ||
| Ally Bridge MedAlpha Master Fund L.P. | 11.3% | ||
| Fan Yu | 11.3% | ||
|
Great Point Partners, LLC
13G/A
Amendment 4
|
10.0% |
11/14/2025
Event 9/30/2025
|
|
| Great Point Partners, LLC | 10.0% | ||
| Dr. Jeffrey R. Jay, M.D. | 10.0% | ||
| Ms. Lillian Nordahl | 10.0% | ||
|
Armistice Capital, LLC
13G/A
Amendment 3
|
5.5% |
11/14/2025
Event 9/30/2025
|
|
| Armistice Capital, LLC | 5.5% | ||
| Steven Boyd | 5.5% | ||
|
ABG Management Ltd.
13D
|
11.3% |
10/29/2025
Event 10/22/2025
|
|
| ABG Management Ltd. | 11.3% | ||
| Ally Bridge Group (NY) LLC | 11.3% | ||
| Ally Bridge MedAlpha Master Fund L.P. | 11.3% | ||
| Fan Yu | 11.3% | ||
|
Sphera Funds Management Ltd.
13G/A
Amendment 2
|
5.5% |
10/23/2025
Event 9/30/2025
|
|
| Sphera Funds Management Ltd. | 5.5% | ||
| Sphera Global Healthcare GP Ltd. | 5.5% | ||
| Sphera Global Healthcare Management LP. | 5.5% | ||
|
Jeremy M. Sclar
13G/A
Amendment 4
|
16.9% |
10/15/2025
Event 9/30/2025
|
|
| Jeremy M. Sclar | 16.9% | ||
| Crocker Mountain LLC | 3.6% | ||
| Jeremy M. Sclar 2012 Irrevocable Family Trust | 13.6% | ||
|
Armistice Capital, LLC
13G/A
Amendment 8
|
8.6% |
8/15/2025
Event 6/30/2025
|
|
| Armistice Capital, LLC | 8.6% | ||
| Steven Boyd | 8.6% | ||
|
Great Point Partners, LLC
13G/A
Amendment 3
|
10.0% |
8/14/2025
Event 6/30/2025
|
|
| Great Point Partners, LLC | 10.0% | ||
| Dr. Jeffrey R. Jay, M.D. | 10.0% | ||
| Ms. Lillian Nordahl | 10.0% | ||
|
Michael S. Gordon
13G/A
Amendment 4
|
9.0% |
8/14/2025
Event 6/30/2025
|
|
| Michael S. Gordon | 9.0% | ||
| Title 19 Promis | 9.0% | ||
|
ABG Management Ltd.
13G
|
11.8% |
8/4/2025
Event 7/29/2025
|
|
| ABG Management Ltd. | 11.8% | ||
| Ally Bridge Group (NY) LLC | 11.8% | ||
| Ally Bridge MedAlpha Master Fund L.P. | 11.8% | ||
| Fan Yu | 11.8% | ||
|
Shaf QIC LLC
13G/A
Amendment 1
|
10.0% |
7/31/2025
Event 7/29/2025
|
|
| Shaf QIC LLC | 10.0% | ||
| Jonathan Shafmaster | 10.0% | ||
|
Armistice Capital, LLC
13G/A
Amendment 2
|
7.1% |
5/15/2025
Event 3/31/2025
|
|
| Armistice Capital, LLC | 7.1% | ||
| Steven Boyd | 7.1% | ||
|
Armistice Capital, LLC
13G/A
Amendment 1
|
7.7% |
2/14/2025
Event 12/31/2024
|
|
| Armistice Capital, LLC | 7.7% | ||
| Steven Boyd | 7.7% | ||
|
Great Point Partners, LLC
13G/A
Amendment 2
|
10.0% |
2/14/2025
Event 12/31/2024
|
|
| Great Point Partners, LLC | 10.0% | ||
| Dr. Jeffrey R. Jay, M.D. | 10.0% | ||
| Ms. Lillian Nordahl | 10.0% |
| Period | Filings | Shares, Excl. Options | Value, Excl. Options |
|---|---|---|---|
| 2025 Q3 | 24 | 9.99 M | $4.25 M |
| 2025 Q2 | 21 | 8.48 M | $4.10 M |
| 2025 Q1 | 18 | 9.33 M | $6.49 M |
| 2024 Q4 | 19 | 9.75 M | $9.24 M |
| 2024 Q3 | 20 | 10.1 M | $12.6 M |
| 2024 Q2 | 18 | 3.26 M | $4.90 M |
| 2024 Q1 | 18 | 3.38 M | $6.46 M |
| 2023 Q4 | 17 | 3.35 M | $3.85 M |
| 2023 Q3 | 15 | 2.81 M | $5.61 M |
| 2023 Q2 | 14 | 187 k | $724 k |
| 2023 Q1 | 13 | 188 k | $889 k |
| 2022 Q4 | 14 | 189 k | $824 k |
| 2022 Q3 | 14 | 185 k | $1.13 M |
| 2022 Q2 | 1 | 10.0 k | $1.00 k |